Recruiting

TMS vs. Sham TMS

Sponsor:

University of Kentucky

Code:

NCT07842601

Conditions

Opioid Use Disorder

Major Depressive Disorder (MDD)

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Transcranial Magnetic Stimulation (TMS)

Sham Transcranial Magnetic Stimulation (TMS)

Study Details

Brief summary:

This study will compare transcranial magnetic stimulation (TMS) with sham TMS in people with opioid use disorder who are taking buprenorphine and have major depressive disorder with ongoing depressive symptoms. The study will evaluate whether TMS improves depressive symptoms and reduces opioid craving. The study will also assess smoking behaviors, treatment acceptability, and any side effects related to TMS.

Conditions

Opioid Use Disorder

Major Depressive Disorder (MDD)

Study ID

NCT07842601

Start date

Nov 11, 2026

Status verified date

Nov, 2026

Completion date

Dec 31, 2028

Anticipated

Primary completion date

Dec 31, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • 18-75 years of age
  • Willing and able to provide informed consent
  • Able to read and speak english
  • Opioid use disorder, in remission for at least a month
  • Diagnosis of major depressive disorder confirmed with the Mini-International Neuropsychiatric Interview (MINI, 7.02)
  • Minimum score of 10 on the 17-item Hamilton Depression Rating Scale (HDRS-17)
  • Opioid craving score of 5 or greater on a 0-10 scale
  • Stabilized on sublingual or depot buprenorphine for at least 8 weeks

Exclusion Criteria:

  • Seizure disorder
  • any other acute medical or behavioral disorder that would preclude safe participation
  • Pregnant, nursing or planning to become pregnant during the study
  • Magnetic resonance imaging (MRI) contraindications, including ferrous retainers, intracranial implants, or claustrophobia
  • Surgical procedure planned during the study period
  • Any other medical condition that could compromise participant well-being

Study Design

Enrollment

60 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Transcranial Magnetic Stimulation (TMS)

Participants will receive active transcranial magnetic stimulation (TMS) using intermittent theta burst stimulation (iTBS).

sham comparator: Sham Transcranial Magnetic Stimulation (TMS)

Participants will receive sham transcranial magnetic stimulation (TMS) using the same treatment procedure without a significant electric field induced around the brain.

Interventions

Transcranial Magnetic Stimulation (TMS)

Intermittent theta burst stimulation (iTBS) delivered over the left dorsolateral prefrontal cortex using a TMS coil.

Sham Transcranial Magnetic Stimulation (TMS)

Sham Transcranial Magnetic Stimulation (TMS) delivered using the same procedure as active TMS without a significant electric field induced around the brain.

Primary outcome measure

  • Change in Depressive Symptom Severity [ Time Frame: Baseline through Week 13 ]
  • Change in Opioid Craving [ Time Frame: Baseline through Week 13 ]

Central Contacts and Locations

Central contacts

Locations

University of Kentucky

Recruiting

Lexington, Kentucky, United States, 40506

Contacts

More Information

Sponsor

University of Kentucky

Last update posted

Nov 17, 2026

Last verified

Nov, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-18. This information was provided to ClinicalTrials.gov by University of Kentucky on 2026-11-17. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.